The Cure Starts Now has funded $25,466,182 (USD) in pediatric brain cancer research in partnership with the DIPG / DMG Collaborative. This includes 170 grants at over 100 hospitals in 29 countries.

Note: All Grants Are U.S. Funded Through 2018



Johns Hopkins Hospital – $100,000

Amount
$100,000.00
Date
December 2024

Leveraging Epigenetic Alterations for Therapy of Diffuse Midline Glioma

CONNECT Consortium (TarGeT 2025) - $32,230 USD / $50,000 AUD

Amount
$32,230.00
Date
December 2024

TarGeT 2025

CONNECT Consortium (TarGeT 2026) - $32,230 USD / $50,000 AUD

Amount
$32,230.00
Date
December 2024

TarGeT 2026

CONNECT Consortium (TarGeT 2027) - $6,445 USD / $10,000 AUD

Amount
$6,445.00
Date
December 2024

TarGeT 2027

Children’s Hospital of Philadelphia – $100,000

Amount
$100,000.00
Date
December 2024

Cytokine Signaling in Diffuse Midline Glioma to Enhance GD2-Directed CAR T Cell Trafficking

UNC Eshelman School of Pharmacy – $50,000

Amount
$50,000.00
Date
December 2024

Leveraging Open Science and Collaboration to Identify Clinical Quality ALK2 Inhibitors for DIPG

Murdoch Children's Research Institute – $100,000 USD / $156,914 AUD

Amount
$100,000.00
Date
December 2024

Harnessing Developmental Neurobiology to Reprogram the Cell of Origin of Diffuse Midline Gliomas

Children’s Cancer Institute – $70,400 USD / $110,467 AUD

Amount
$70,400.00
Date
December 2024

A Novel Formulation to Allow the Simultaneous Targeting of MYC Expression and Copper Chelation to Treat DIPG Tumor and Overcome Multidrug Resistance

The Institute for Medical Research Israel-Canada – $40,000 USD / 143,580 INS

Amount
$40,000.00
Date
December 2024

CXCR1/2 Signaling Pathway: A Role in the Invasive Mechanism of DIPG

Children's Healthcare of Atlanta – $100,000

Amount
$100,000.00
Date
November 2024

Radiation Resistance in Medulloblastoma

University of Texas Health Science Center at San Antonio – $100,000

Amount
$100,000.00
Date
November 2024

Targeting Metabolic Vulnerabilities for Treating Medulloblastoma

University of Texas Health Science Center at San Antonio – $50,000

Amount
$50,000.00
Date
November 2024

Targeting RRNA Modification and SNORNA Function, A Novel Concept to Treat Aggressive Medulloblastoma

Children’s National Medical Center – $300,000

Amount
$300,000.00
Date
November 2024

Multilamellar H3K27M RNA aggregates targeting diffuse midline glioma, including diffuse intrinsic pontine glioma.

Children's Hospital Los Angeles – $100,000

Amount
$100,000.00
Date
October 2024

Targeting FOXR2 in Diffuse Midline Gliomas

University Hospital of Navarra - $100,000 USD, €92,637 EUR

Amount
$100,000.00
Date
October 2024

Targeting Diffuse Midline Glioma vulnerabilities as a therapeutic strategy.